Opendata, web and dolomites

BQ-Technology

BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BQ-Technology project word cloud

Explore the words cloud of the BQ-Technology project. It provides you a very rough idea of what is the project "BQ-Technology" about.

natural    patterns    artificial    viral    connected    stimulation    dementia    operator    stroke    neural    designed    treatment    aging    global    cloud    risk    motor    algorithms    disorders    populations    agnostic    easily    dependent    decreased    scalable    injuries    intelligence    decade    paralysed    clinical    perform    attributable    daily    human    functional    waves    doubles    frequency    materials    sensor    impaired    brain    interface    anomalous    animal    infections    care    age    deficits    demonstrated    causes    brainq    invasive    device    treat    proprietary    restore    electromagnetic    patient    recovery    impairments    globally    neurological    frequencies    neuro    sensorimotor    indication    remarkable    continue    first    computer    eeg    uses    rehabilitation    55    translated    living    regain    cognitive    bq    prevalence    efficacy    linked    healthcare    world    time    disability    variety    mortality    triggers    burden    strokes    back    feet    network    patients    skills    spectral    operated    death    trials    bill    revolutionary   

Project "BQ-Technology" data sheet

The following table provides information about the project.

Coordinator
BRAINQ TECHNOLOGIES LTD 

Organization address
address: 4/4 HIGH TECH VILLAGE GIVAT RAM
city: JERUSALEM
postcode: 39129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://brainqtech.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BRAINQ TECHNOLOGIES LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

The WHO has identified neurological disorders as a major burden and emerging challenge to global healthcare systems. These range from causes such as stroke and dementia, to injuries and viral infections. The prevalence of strokes and dementia are strongly linked to increasing age, for example stroke risk more than doubles every decade after 55 . Although, mortality attributable to stroke has decreased over time Stroke remains a leading cause of death and disability globally and can cause significant deficits in sensorimotor skills and cognitive abilities.

With the increasingly aging populations across the world and particularly in Europe, the burden of care from Neurological disorders is set to continue increasing.

BrainQ’s BQ system is a revolutionary Brain Computer Interface-based stimulation device used to enhance neuro-recovery. Our device uses proprietary, artificial intelligence algorithms to identify anomalous spectral patterns in patient's brain waves (“EEG”). These patterns are then translated into a tailored frequency dependent electromagnetic treatment targeting specific impaired functional neural network associated with these frequencies and triggers natural rehabilitation thus promoting neuro recovery process.

Device is designed to enable non-invasive treatment for motor impairments following a variety of neurological disorders; help patients get back on their feet and restore their ability to perform activities of daily living. Treatment is tailored to each patient, is patient friendly, non-invasive, cloud connected & scalable, with low Bill of Materials, and operator & indication agnostic. This means it is easily operated and can be used to treat a variety of neurological disorders. Pre-clinical animal trials and first-in-human clinical trials have demonstrated remarkable efficacy, allowing paralysed patients regain sensor and motor abilities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BQ-TECHNOLOGY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BQ-TECHNOLOGY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More